Ionis Pharmaceuticals, Inc.
METHODS AND COMPOSITIONS FOR INHIBITING PMP22 EXPRESSION
Last updated:
Abstract:
The present embodiments provide methods, compounds, and compositions useful for inhibiting PMP22 expression and for treating, preventing, or ameliorating a disease associated with PMP22.
Status:
Application
Type:
Utility
Filling date:
4 Oct 2021
Issue date:
11 Aug 2022